1. Development of registry data to create interactive doctor-patient platforms for personalized patient care, taking the example of the DESTINY system;Bergmann;Front. Digit. Health,2021
2. Secondary progressive multiple sclerosis: new insights;Cree;Neurology,2021
3. Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers;Forsberg;Mult. Scler. J.- Exp., Transl. Clin.,2023
4. The uncertainty period preceding the clinical defined SPMS diagnosis and the applicability of objective classifiers - a Danish single center study;Holm;Mult. Scler. Relat. Disord.,2023
5. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study;Kappos;Lancet,2018